l General Information |
Product Name | Fosinopril Sodium |
General description | Fosinopril Sodium is the ester prodrug of an angiotensin-converting enzyme (ACE) inhibitor, used for the treatment of hypertension and some types of chronic heart failure. |
Synonym | SQ28555 |
Purity | ≥98.0%(HPLC) | CAS Number | 88889-14-9 |
Formula | C30H45NNaO7P | Molecular Weight | 585.654 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White powder |
Solubility(25°C) | DMSO | Insoluble |
Ethanol | ~5mg/mL |
Water | ≥50mg/mL |
l Biological Information |
Biochem/Physiol
Actions | Fosinopril Sodium is the sodium salt of fosinopril, a phosphinic acid-containing angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity. Fosinopril sodium is an ester prodrug that is hydrolysed by esterases to its active metabolite fosinoprilat. Fosinoprilat specifically and competitively inhibits angiotensin-converting enzyme thereby decreasing the formation of the potent vasoconstrictor angiotensin II, resulting in diminished vasopressor activity. In addition, angiotensin II-mediated aldosterone secretion by adrenal cortex is decreased, which results in a decrease of sodium retention and an increase of serum potassium. |
l Storage |
Storage temp. | 0-5°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |